Synonyms:
Status: Phase 1
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: 802IFJ0Z8X

Structure

InChI Key FAYAUAZLLLJJGH-UHFFFAOYSA-N
Smile O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1
InChI
InChI=1S/C18H15ClN6OS2/c19-11-2-1-3-12(8-11)24-17(26)25-18-21-9-13(28-18)4-6-20-16-15-14(5-7-27-15)22-10-23-16/h1-3,5,7-10H,4,6H2,(H,20,22,23)(H2,21,24,25,26)

Physicochemical Descriptors

Property Name Value
Molecular Formula C18H15ClN6OS2
Molecular Weight 430.95
AlogP 4.52
Hydrogen Bond Acceptor 6.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 5.0
Polar Surface Area 95.06
Molecular species NEUTRAL
Aromatic Rings 4.0
Heavy Atoms 28.0

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Serine/threonine-protein kinase Aurora inhibitor PubMed PubMed
Primary Target
aurora kinase A
aurora kinase B

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 1 D009369 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1057249-41-8
ChEBI 94720
ChEMBL CHEMBL482767
DrugBank DB06134
EPA CompTox DTXSID20147269
FDA SRS 802IFJ0Z8X
Guide to Pharmacology 9397
PDB AK2
PubChem 24995524
SureChEMBL SCHEMBL3415843
ZINC ZINC000040393428